Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.00 USD
Change Today +0.16 / 1.81%
Volume 2.9M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John O. Marsh Jr., J.D.

Director Emeritus, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 2 different industries.

See Board Relationships
87$147,815

Background*

Mr. John O. Marsh, Jr. serves as a Senior Fellow at the National Center for Technology and Law. Mr. Marsh is a Visiting Professor, George Mason University since 2000; Visiting Professor, Virginia Military Institute during 1998; Interim Chief Executive Officer and Chairman of the Director of Novavax, Inc. from 1996 to 1997; Secretary of the Army from 1981 to 1989; Counselor with Cabinet rank to the President of the United States from 1974 to 1977; Assistant for National ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

1991-2014
Director Emeritus

Education*

Unknown/Other Education
Washington University, St. Louis
LLB
Lee University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$28,400
Total Calculated Compensation$147,815
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $9.00 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$515.0K
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
$886.6K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
Anthony S. Marucci M.B.A.Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$814.1K
Laurence James Neil Cooper Ph.D., M.D.Chief Executive Officer
ZIOPHARM Oncology, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.